Table 4. Phenotypic characterization of ADHLSC and HSC by flow cytometry for mesenchymal stem cells, hematopoietic cells and extracellular matrix markers.

				ADHLSC		HSC
				P5	P11	P5	P11
Mesenchymal stem cells markers
			ASMA	87,8±4,7%	83,8±2,9%	91,9±5,5%	87,4±12,6%
			CD73	88,2±5,9%	90,2±6,1%	89,9±2,5%	82,8±20,1%
			CD90	97,2±2,7%	92,7±7,8%	95,6±2,3%	88,7±10,4%
Hematopoietic cells markers
			CD133	0,7±0,2%	1,3±0,3%	2,1±2,2%	2,2±2,3%
			CD45	1,4±0,8%	2,6±3,1%	1,7±1,0%	1,8±1,9%
			CD117	0±0%	0,07±0,12%	0,3±0,4%	0,03±0,06%
Extracellular matrix markers
			CD49b	95,6±1,1%	95,5±2%	89,7±8,0%	90±9,7%
			CD29	86,4±10,2%	60,8±11%	77±21,5%	56,6±49,64%
			CD44	77,5±8,6%	79,7±9,2%	68±4,1%	75±18,9%

Data presented as mean percentage of immunopositive cells from four different donors at early (P5) and late(P11) passages. No significant difference was observed between the two cell populations.